查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1832183

动物遗传学市场（按动物种类、技术、应用和最终用户划分）—2025-2032 年全球预测

Animal Genetics Market by Animal Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，动物遗传学市场将成长至 148.8 亿美元，复合年增长率为 9.55%。

主要市场统计数据
基准年2024年 71.7亿美元
预计2025年 78.4亿美元
预测年份：2032年 148.8亿美元
复合年增长率（%） 9.55%

简要介绍影响现代动物遗传学创新和产业决策的不断发展的科学、商业、监管和道德格局

动物遗传学领域如今在粮食安全、永续生产和转化生物技术的交叉领域中占据核心地位。分子工具和数据分析领域的科学进步正在加速遗传变异的识别、检验和应用于育种计划的速度。同时，商业公司和公共机构正面临影响其部署轨蹟的复杂问题，包括伦理问题、不断变化的法规以及相关人员不断变化的期望。

本报告总结了当代影响动物遗传学研究和商业化的驱动因素，并强调了其对研究人员、育种者、政策制定者和投资者的实际意义。报告从技术能力、应用主导价值和机构采用模式等方面对该领域进行了概述。引言部分整合了实验室创新、产品开发平臺和监管讯号的证据，帮助读者了解该领域面临的关​​键挑战和机会。

读者可以期待一种结合技术清晰度和战略洞察力的平衡观点，旨在为决策者提供一个框架，阐明科学前景与可行实施之间的一致性，其中最大的障碍仍然存在，以及可以在不同的组织目标中创造可持续优势的近期行动。

技术、监管和商业性趋势的综合视角正在从结构上再形成动物遗传学创新从实验室走向大规模部署的方式

在精准生物学、计算分析和相关人员影响力的共同推动下，动物遗传学领域正经历一场变革性转变。基因编辑工具日益复杂化和普及化，使得先前仅停留在理论层面的针对性干预措施成为可能。同时，基因组选择和高通量表型分析正在将海量资料集转化为持续可操作的育种决策。这些技术变革，加上育种技术和资料基础设施的改进，正在缩短转换时间并降低单位开发成本。

同时，社会和监管因素正在重塑部署策略。公众对基因介入的审查、对动物福利日益增长的担忧以及对透明度的不断提升的期望，促使上市公司和机构设计优先考虑可追溯性、严格的安全评估和有意义的相关人员参与的途径。有些国家正在寻求建立一个能够负责任地管理基因编辑的框架，而有些国家则强调预防。这种监管异质性正在推动跨市场的策略性细分，而敏捷的组织正在投资能够适应不同核准途径的模组化开发计划。

商业性，技术发起者、商业育种者和产品整合商之间的伙伴关係正成为扩大规模的主导模式。垂直整合和联盟式合作正成为共用开发风险、汇集专业知识和加速终端用户获取的可行方式。总而言之，这些趋势不仅代表遗传科学从实验室示范走向动物群体实用化的渐进式转型，更代表结构性的重建。

美国近期的2025年关税调整如何加速供应链区域化，并导致采购、伙伴关係和国内产能建置的策略转变

贸易政策和关税制度的变化可能会对供应链的逻辑、采购决策以及跨境研究合作的经济效益带来重大变化。 2025年，美国实施了累积关税调整，为基因输入、序列测定设备和专用试剂的国际供应商以及依赖进口基因材料和基因编辑平台的公司带来了新的考量。这些政策发展凸显了在地化供应弹性的重要性，并促使相关人员重新评估筹资策略和区域伙伴关係。

因此，许多公司采取了以下措施：多元化供应商网路、扩大区域生产能力，并加快替代供应商的资格审核，以减少对单一来源的依赖。研究合作和测试流程也调整了计划，以应对潜在的海关延误和增加的文件要求。对于进口遗传材料或依赖跨境育种品质交换的育种项目而言，海关环境带来了额外的行政复杂性和成本压力，影响了营运的优先顺序。

重要的是，这些政策转变重新引发了关于国内能力建构的讨论。公共和私营相关人员纷纷支持本地基础设施投资，从低温保存设施到定序和生物资讯平台，以保持策略自主权并保障育种时间表。虽然关税并没有改变基础科学潜力，但它确实成为区域化和供应链现代化策略的催化剂。

一个策略性细分框架，将动物物种、实行技术、应用优先顺序和最终用户动机结合起来，以指导投资和发展决策

细緻的细分观点能够清楚阐明生物机会与商业性途径和监管摩擦之间的对应关係。就动物物种而言，研究和应用涵盖水产养殖、家牛、家禽和猪，其中家牛进一步细分为具有不同繁殖目标、生产限制和价值驱动力的肉牛和酪农企业。这种物种差异会影响技术优先顺序和最终用户参与度，因为高通量水产养殖计画与多代肉牛牛群的生物目标、繁殖週期和经济奖励有显着差异。

从技术角度来看，克隆、基因编辑、基因组选择和标记辅助选择目前在该领域以互补的方式部署。在基因编辑领域，CRISPR/Cas9、TALEN 和 ZFN 等技术在精确度、易实施性和监管核准方面各有优劣，这些技术属性显示哪些工具更适合特定途径的目标。由于同一基因组工具可能根据实验设计和检验策略针对抗病性、饲料效率、生育力、生长率或产乳量进行最佳化，因此根据应用需求选择合适的技术至关重要。

应用主导的细分显示，抗病性和饲料效率等目标通常透过降低生产风险和投入成本来提供跨产业价值，而生育率、生长率和产奶量则与特定品种的商业性目标密切相关。最终用户包括学术机构、商业育种者、政府机构、製药公司和研究机构，每个群体都为开发项目带来不同的奖励、营运节奏和风险接受度。此细分框架提供了一个实用的视角，可用于确定投资优先顺序、设计检验路径，以及将创新转化为常规实践所需参与的相关人员。

区域分析揭示了美洲、欧洲、中东和非洲以及亚太地区的政策制度、能力水准和商业结构如何变化，从而影响采用和扩大规模的途径

区域动态显着影响基因创新的监管、资助和应用方式。在美洲，强劲的私人投资、一体化的价值链和广泛的商业育种基础设施创造了良好的环境，一旦监管明确，转化研究就能迅速扩大规模。北美和南美市场拥有不同的消费者偏好和政策框架，这反过来又影响技术部署和产业合作的速度和模式。

欧洲、中东和非洲呈现出不同的监管理念和能力水准。在欧洲地区，通常高度重视预防措施、可追溯性和广泛的相关人员咨询，这些因素会影响产品设计和传播策略。相较之下，中东和非洲部分地区则优先考虑透过公共投资和国际伙伴关係支持的有针对性的育种计画来快速提高生产力。解决这些地区差异需要采取适应性的监管策略和与当地相关的示范计划，以建立信誉并获得企业认可。

亚太地区虽然差异巨大，但也存在通用，包括政府主导的强大研发重点、数位农业工具的快速应用以及集约化的工业规模水产养殖和畜牧生产。该地区各国正在投资基因组基础设施和公私合营关係，以应对粮食安全和出口竞争力问题。总体而言，区域差异凸显了根据每个地理区域独特的社会政治和经济现实，量身定制开发平臺、监管参与和相关人员拓展的重要性。

深入了解企业策略、伙伴关係和能力整合，这将决定哪些组织能够有效地将遗传学创新转化为可扩展的商业性解决方案

动物遗传学领域的公司和组织的行为日益体现出科学专业化与平台整合的整合。拥有强大知识产权组合、可扩展实验室工作流程和监管专业知识的技术提供者正将自己定位为下游育种和商业化的推动者。许多组织正在推行双重策略：一方面自主开发核心平台能力，另一方面与商业育种者和研究机构合作进行实地检验和推广。

策略联盟十分常见，技术发起者与育种公司合作，将基因组解决方案整合到现有研发管线中，而合约研究机构和服务实验室则为检测标准化和监管文件提供支援。对专有数据资产和表型关联基因组资料库的投资已成为竞争优势，为模型准确性和产品可预测性奠定了基础。同时，重视透明检验、第三方复製和监管参与的公司可以降低上市时间风险，并增强相关人员的信心。

併购仍然是获取能力的重要途径，尤其是在企业寻求将分子套件与动物育种专业知识相结合，或获取区域重要育种性状或分销管道的情况下。在整个生态系统中，成功的企业能够平衡科学卓越性与切合实际的商业化路径，投资于监管和道德管治，并保持灵活的伙伴关係模式，以便在技术和市场信号一致时快速扩张。

可操作的、实用的建议，以协调技术优先、管治、供应弹性和资料能力，从而加速负责任的部署和商业性成功

产业领导者应采取投资组合策略，平衡短期营运收益与长期平台建置。优先考虑针对高影响力应用的计划，例如抗病性和饲料效率，因为这些目标通常能为生产者带来明确、可衡量的效益，同时也能即时降低生产风险和投入成本。此外，还应选择性地投资于提高生育力和产奶量，透过品种稳定性和长期基因管理，在多个週期内放大回报。

管治和相关人员的参与同样重要。建立透明的检验流程，尽可能发布重复研究，并在获得可接受证据的阈值与监管机构沟通。积极设计动物福利评估和公共关係策略，以建立社会许可。在营运方面，要多元化供应商关係，确定区域生产和定序能力，并结合情境规划来应对政策和贸易干扰。利用与学术和研究机构的伙伴关係关係，获取专业知识并分担检验负担。

最后，投资数据基础设施和人力资本。高品质的表型关联基因组资料库、可互通的分析平台以及高技能的跨学科团队，对于将实验室创新转化为可重复的现场成果至关重要。透过将科学严谨性与灵活的商业化计划和强有力的相关人员参与相结合，行业领导者可以加速负责任的部署，同时管理风险并提升长期价值创造。

结合专家访谈、文献综合、专利和政策审查以及情境分析的严格混合方法研究途径提供了检验的产业见解

该调查方法结合了定性和定量证据流，对动物遗传学领域进行了稳健且可复製的分析。主要研究包括对专家、育种者、监管专业人员和研发人员的结构化访谈，以了解营运现状、策略重点以及已发表文献中未提及的痛点。此外，还举办了研讨会和专家小组讨论，以检验新的假设并完善情境假设。

二次研究系统地回顾了同行评审文献、专利申请、监管指导文件和技术白皮书，以绘製技术发展轨迹并识别有效的用例。此外，比较政策分析探讨了各辖区在基因编辑、可追溯性和动物福利方面的做法，并提供了特定地区的建议。数据合成利用了主要见解与记录证据的交叉检验，并透过情境分析对研究结果进行压力测试，以探索可行的政策和市场发展。

最后，我们透过反覆检验以及透明地记录资料来源和分析假设，确保了调查方法和资料来源的严谨性。对于存在不确定性的情况，我们运用保守推理原则，并说明其他解释，以帮助读者评估风险及其在自身决策情境中的适用性。

简要总结结论，平衡动物遗传学的科学前景与监管、检验和相关人员接受的实际考虑。

现代动物遗传学生态系统蕴含着巨大的机会，但也受到复杂的监管、伦理和营运限制的限制。基因编辑、基因组选择和先进育种方法等技术工具提供了精准的槓桿，可以提高抗病性、饲料效率、繁殖力、生长率和产乳量。然而，大规模应用取决于科学检验、监管认可、供应链韧性以及相关人员信任之间的协调。

策略差异化将来自那些将卓越的科学成果与灵活的商业化策略相结合的组织——这些组织投资于高品质的表型相关数据，设计严格透明的检验方案，并建立连接实验室创新和现场应用的伙伴关係关係。区域政策多样性和不断变化的贸易环境需要灵活的计划，这些计划既能适应本地情况，又能保持全球互通性。透过优先考虑可降低生产风险的应用，并建立能够预见社会关切的管治，相关人员可以负责任地加速转换进程。

总而言之，该领域正在从探索性研究转向实用且可部署的干预措施。未来的道路强调实用科学、严谨的检验以及与监管机构和公众的积极互动，以确保基因创新在生产、健康和永续性目标方面带来持久的效益。

目录

第一章 引言

第二章分析方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 整合CRISPR碱基编辑技术，提升牲畜抗病能力与生产力
  • 应用表观遗传标记预测极端气候条件下乳牛的耐热性
  • 利用机器学习驱动的基因组选择演算法加速猪隻生长性状发育
  • 开发结合总体基因体学学和宿主基因组学的多体学方法来改善家禽肠道健康和性能
  • 透过先进的基因组分析扩大精准育种计划，减少反刍动物甲烷排放
  • 利用 CRISPR 基因编辑技术将多个有益等位基因引入栽培物种，以增强抗病能力
  • 实施基于区块链的基因组数据共用平台，确保全球畜牧业实践的可追溯性
  • 将人工智慧融入表型组学，实现牲畜高通量性状测量和分析的自动化

第六章：美国关税的累积影响（2025年）

第七章：人工智慧（AI）的累积影响（2025年）

第 8 章：动物遗传学市场（按动物类型）

  • 水产养殖
  • 牛
    • 肉牛
    • 乳牛
  • 家禽
  • 猪

9. 动物遗传学市场（按技术）

  • 复製
  • 基因编辑
    • CRISPR/Cas9
    • TALEN
    • ZFN
  • 基因组选择
  • 标记辅助选择

第 10 章：动物遗传学市场（按应用）

  • 抗病性
  • 饲料效率
  • 生育能力
  • 成长率
  • 牛奶产量

第 11 章动物遗传学市场（按最终用户）

  • 学术机构
  • 商业育种者
  • 政府机构
  • 製药公司
  • 研究所

第 12 章：按地区分類的动物遗传学市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章：动物遗传学市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按国家/地区分類的动物遗传学市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 市占率分析（2024年）
  • FPNV定位矩阵（2024年）
  • 竞争情境分析
    • Genus plc
    • Hendrix Genetics NV
    • Topigs Norsvin Holding AS
    • Aviagen International, Inc.
    • Neogen Corporation
    • Zoetis Inc.
    • CRV BV
    • STgenetics, Inc.
    • Genesus Inc.
    • Lohmann Tierzucht GmbH
Product Code: MRR-4358BACA7E12

The Animal Genetics Market is projected to grow by USD 14.88 billion at a CAGR of 9.55% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.17 billion
Estimated Year [2025] USD 7.84 billion
Forecast Year [2032] USD 14.88 billion
CAGR (%) 9.55%

A concise introduction outlining the evolving scientific, commercial, regulatory, and ethical landscape shaping modern animal genetics innovation and industry decision-making

The field of animal genetics now occupies a central role at the intersection of food security, sustainable production, and translational biotechnology. Scientific advances in molecular tools and data analytics have accelerated the pace at which genetic variation can be identified, validated, and applied to breeding programs. At the same time, commercial players and public institutions confront a complex web of ethical questions, evolving regulation, and shifting stakeholder expectations that shape deployment pathways.

This report synthesizes the contemporary drivers shaping animal genetics research and commercialization, emphasizing the practical implications for researchers, breeders, policy makers, and investors. It frames the sector in terms of technological capability, application-driven value, and institutional adoption patterns. By integrating evidence from laboratory innovations, product development pipelines, and regulatory signals, the introduction grounds readers in the landscape's critical tensions and opportunities.

Readers should expect a balanced perspective that pairs technical clarity with strategic insight. The goal is to equip decision-makers with a framework that clarifies where scientific promise aligns with feasible implementation, where barriers remain most material, and where near-term actions can create durable advantage across diverse organizational objectives.

An integrated view of converging technological, regulatory, and commercial trends that are structurally reshaping how animal genetics innovations progress from lab to large-scale deployment

The animal genetics landscape is in the midst of transformative shifts driven by converging advances in precision biology, computational analytics, and stakeholder influence. Gene editing tools, increasingly refined and democratized, are enabling targeted interventions that were previously theoretical, while genomic selection and high-throughput phenotyping are turning large datasets into consistently actionable breeding decisions. These technological shifts are complemented by improvements in reproductive technologies and data infrastructure that together compress translational timelines and lower per-unit development costs.

Concurrently, societal and regulatory vectors are reshaping deployment strategies. Public scrutiny of genetic interventions, elevated attention to animal welfare, and heightened expectations for transparency are prompting companies and institutions to design pathways that prioritize traceability, rigorous safety assessment, and meaningful stakeholder engagement. Policy environments are also evolving; some jurisdictions pursue enabling frameworks for responsibly managed gene editing, while others emphasize precaution. This regulatory heterogeneity is catalyzing strategic segmentation across markets, with agile organizations investing in modular development plans that can be adapted to divergent approval pathways.

Commercially, partnerships between technology originators, commercial breeders, and product integrators are becoming the predominant model for scaling. Vertical integration and consortium-style collaborations are emerging as pragmatic ways to share development risk, consolidate expertise, and accelerate access to end users. Taken together, these trends are not merely incremental; they represent a structural reconfiguration of how genetic science moves from laboratory proofs to operational use in animal populations.

How recent United States tariff adjustments in 2025 accelerated supply-chain regionalization and strategic shifts across procurement, partnerships, and domestic capacity building

Changes in trade policy and tariff regimes can produce material shifts in supply chain logic, sourcing decisions, and the economics of cross-border research collaborations. In 2025, cumulative tariff adjustments in the United States introduced new considerations for international suppliers of genetic inputs, sequencing equipment, and specialized reagents, as well as for firms that rely on imported genetic materials or gene-editing platforms. These policy moves have amplified the importance of localized supply resilience and have prompted stakeholders to re-evaluate procurement strategies and partnership geographies.

As a result, many firms responded by diversifying supplier networks, expanding regional manufacturing capacity, and accelerating qualification of alternative vendors to reduce single-source dependencies. Research collaborations and trial pipelines adjusted timelines to account for possible customs delays and increased documentation requirements. For breeding programs that import genetic material or rely on cross-border exchange of germplasm, the tariff environment created additional administrative complexity and incremental cost pressure that affected operational prioritization.

Importantly, these policy shifts also reanimated discussions about domestic capability building. Public and private actors moved to support local infrastructure investments, from cryopreservation facilities to sequencing and bioinformatics platforms, in order to preserve strategic autonomy and protect breeding timelines. While tariffs did not change the underlying scientific potential, they acted as an accelerant for regionalization and supply-chain modernization strategies which will continue to influence project design and partnership choices going forward.

A strategic segmentation framework that aligns animal types, enabling technologies, application priorities, and end-user motivations to guide investment and development decisions

A nuanced segmentation view clarifies where biological opportunity aligns with commercial pathways and regulatory friction. When considering animal type, research and applications span aquaculture, cattle, poultry, and swine, with cattle further differentiated into beef and dairy enterprises that have distinct breeding objectives, production constraints, and value drivers. These animal-type distinctions influence prioritization of technologies and end-user engagement because the biological targets, breeding cycles, and economic incentives differ markedly between, for example, a high-throughput aquaculture program and a multi-generational beef cattle herd.

From a technology standpoint, the sector now deploys cloning, gene editing, genomic selection, and marker assisted selection in complementary ways. Within gene editing, techniques such as CRISPR/Cas9, TALEN, and ZFN present different trade-offs of precision, ease of adoption, and regulatory recognition, and these technical attributes inform which tools are suitable for pathway-specific goals. Aligning technology choice with application needs is crucial because the same genomic tool can be optimized for disease resistance, feed efficiency, fertility, growth rate, or milk production depending on experimental design and validation strategy.

Application-driven segmentation reveals that objectives like disease resistance and feed efficiency often deliver cross-sector value by reducing production risk and input costs, while fertility, growth rate, and milk production are tightly linked to breed-specific commercial objectives. End users encompass academic institutes, commercial breeders, government agencies, pharmaceutical companies, and research institutes, and each group brings different incentives, operational tempos, and risk tolerances to development programs. Taken together, this segmentation framework provides a practical lens to prioritize investments, design validation pathways, and map the stakeholders that must be engaged to move innovations into routine practice.

A regional analysis revealing how divergent policy regimes, capacity levels, and commercial structures across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and scale-up pathways

Regional dynamics materially influence how genetic innovations are regulated, funded, and adopted. In the Americas, strong private-sector investment, integrated value chains, and a large commercial breeding infrastructure create an environment where translational work can scale quickly once regulatory clarity is achieved. North and South American markets present differentiated consumer preferences and policy frameworks, which in turn shape the pace and modalities of technology deployment and industry collaboration.

Europe, the Middle East, and Africa present a mosaic of regulatory philosophies and capacity levels. The European sphere often emphasizes precaution, traceability, and extensive stakeholder consultation, which influences product design and communications strategy. By contrast, parts of the Middle East and Africa are prioritizing rapid productivity gains through targeted breeding initiatives, often supported by public investment and international partnerships. These regional differences necessitate adaptive regulatory strategies and locally relevant demonstration projects to build credibility and operational buy-in.

Asia-Pacific reflects high heterogeneity but shares common features of strong government-led R&D priorities, rapid adoption of digital agricultural tools, and concentrated pockets of industrial-scale aquaculture and livestock production. Countries in this region are investing in genomic infrastructure and public-private collaborations to address food security and export competitiveness. Collectively, regional variation underscores the importance of tailoring development pipelines, regulatory engagement, and stakeholder outreach to the specific socio-political and economic realities of each geographic context.

Insight into corporate strategies, partnerships, and capability consolidation that determine which organizations effectively translate genetics innovations into scalable commercial solutions

Corporate and institutional behavior in animal genetics increasingly reflects a blend of scientific specialization and platform consolidation. Technology providers that combine robust intellectual property portfolios with scalable laboratory workflows and regulatory expertise are positioned to act as enablers for downstream breeding and productization. Many organizations pursue a dual strategy of in-house development for core platform capabilities while partnering with commercial breeders and research institutes for field validation and distribution.

Strategic alliances are a common pattern: technology originators collaborate with breeding companies to integrate genomic solutions into existing pipelines, while contract research organizations and service laboratories offer assay standardization and regulatory dossier support. Investment in proprietary data assets and phenotype-linked genomic databases has emerged as a competitive differentiator because it underpins model accuracy and product predictability. At the same time, companies that prioritize transparent validation, third-party replication, and engagement with regulatory authorities reduce time-to-market risk and enhance stakeholder trust.

Mergers and acquisitions remain an important avenue for capability acquisition, particularly where firms seek to combine molecular toolkits with animal breeding expertise or to secure access to regionally important germplasm and distribution channels. Across the ecosystem, successful companies balance scientific excellence with pragmatic commercialization pathways, invest in regulatory and ethical governance, and maintain flexible partnership models that permit rapid scaling when technical and market signals align.

Actionable and practical recommendations that align technology prioritization, governance, supply resilience, and data capabilities to accelerate responsible deployment and commercial success

Industry leaders should pursue a portfolio approach that balances near-term operational gains with longer-term platform creation. Prioritize projects that address high-impact applications such as disease resistance and feed efficiency because these objectives often yield immediate reductions in production risk and input costs while providing clear, measurable benefits to producers. Complement these efforts with selective investments in fertility and milk production improvements where breed stability and long-term genetic stewardship can amplify returns over multiple cycles.

Governance and stakeholder engagement are equally important. Establish transparent validation pipelines, publish replication studies where feasible, and engage with regulators early to align on acceptable evidence thresholds. Proactively design animal welfare assessments and public communication strategies to build social license. From an operational perspective, diversify supplier relationships, qualify regional manufacturing and sequencing capacity, and embed scenario planning to absorb policy or trade disruptions. Leverage partnerships with academic institutes and research organizations to access specialized expertise and to share validation burden.

Finally, invest in data infrastructure and human capital. High-quality phenotype-linked genomic databases, interoperable analytics platforms, and skilled multidisciplinary teams are essential to convert laboratory innovations into reproducible field outcomes. By integrating scientific rigor with adaptive commercialization plans and robust stakeholder engagement, industry leaders can accelerate responsible deployment while managing risk and enhancing long-term value creation.

A rigorous mixed-methods research approach combining expert interviews, literature synthesis, patent and policy review, and scenario analysis to produce validated industry insights

The research methodology combines qualitative and quantitative evidence streams to produce a robust, reproducible analysis of the animal genetics landscape. Primary research included structured interviews with domain experts, breeders, regulatory specialists, and technology developers to capture operational realities, strategic priorities, and pain points that are not visible in published literature. These interviews were complemented by targeted workshops and expert panels that validated emerging hypotheses and refined scenario assumptions.

Secondary research incorporated a systematic review of peer-reviewed literature, patent filings, regulatory guidance documents, and technical whitepapers to map technological trajectories and identify validated use cases. In addition, comparative policy analysis examined jurisdictional approaches to gene editing, traceability, and animal welfare to inform region-specific recommendations. Data synthesis leveraged cross-validation between primary insights and documented evidence, and findings were stress-tested through scenario analysis to explore plausible policy and market evolutions.

Finally, methodological rigor was maintained through iterative validation steps and transparent documentation of data sources and analytical assumptions. Where uncertainty remained, conservative inference principles were applied and alternative interpretations were described to ensure readers can assess risk and applicability to their own decision contexts.

A concise concluding synthesis that balances the scientific promise of animal genetics with pragmatic considerations for regulation, validation, and stakeholder acceptance

The contemporary animal genetics ecosystem presents significant opportunities tempered by complex regulatory, ethical, and operational constraints. Technological tools such as gene editing, genomic selection, and advanced reproductive methods provide precise levers to improve disease resistance, feed efficiency, fertility, growth rate, and milk production. However, adoption at scale depends on alignment between scientific validation, regulatory acceptance, supply-chain resilience, and stakeholder trust.

Strategic differentiation will come from organizations that integrate scientific excellence with adaptive commercialization strategies: those that invest in high-quality phenotype-linked data, design rigorous and transparent validation programs, and cultivate partnerships that bridge laboratory innovation with field implementation. Regional policy diversity and evolving trade environments demand flexible plans that can be localized while preserving global interoperability. By prioritizing applications that reduce production risk and by building governance practices that anticipate societal concerns, stakeholders can responsibly accelerate translational progress.

In sum, the sector is moving from exploratory research toward practical, deployable interventions. The path forward emphasizes pragmatic science, robust validation, and proactive engagement with regulators and the public to ensure genetic innovations deliver durable benefits across production, health, and sustainability objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of CRISPR base editing technologies to enhance livestock disease resistance and productivity
  • 5.2. Application of epigenetic markers to predict heat tolerance in dairy cattle under extreme climate conditions
  • 5.3. Use of genomic selection algorithms powered by machine learning to accelerate swine growth trait development
  • 5.4. Development of multiomics approaches combining metagenomics and host genomics to improve poultry gut health and performance
  • 5.5. Expansion of precision breeding programs targeting methane emission reduction in ruminants through advanced genomic assays
  • 5.6. Adoption of CRISPR prime editing to introduce multiple beneficial alleles in aquaculture species for enhanced disease resilience
  • 5.7. Implementation of blockchain-enabled genomic data sharing platforms to ensure traceability in global animal breeding practices
  • 5.8. Integration of artificial intelligence in phenomics to automate high-throughput trait measurement and analysis in livestock

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Genetics Market, by Animal Type

  • 8.1. Aquaculture
  • 8.2. Cattle
    • 8.2.1. Beef Cattle
    • 8.2.2. Dairy Cattle
  • 8.3. Poultry
  • 8.4. Swine

9. Animal Genetics Market, by Technology

  • 9.1. Cloning
  • 9.2. Gene Editing
    • 9.2.1. CRISPR/Cas9
    • 9.2.2. TALEN
    • 9.2.3. ZFN
  • 9.3. Genomic Selection
  • 9.4. Marker Assisted Selection

10. Animal Genetics Market, by Application

  • 10.1. Disease Resistance
  • 10.2. Feed Efficiency
  • 10.3. Fertility
  • 10.4. Growth Rate
  • 10.5. Milk Production

11. Animal Genetics Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Commercial Breeders
  • 11.3. Government Agencies
  • 11.4. Pharmaceutical Companies
  • 11.5. Research Institutes

12. Animal Genetics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Animal Genetics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Animal Genetics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Genus plc
    • 15.3.2. Hendrix Genetics N.V.
    • 15.3.3. Topigs Norsvin Holding A.S.
    • 15.3.4. Aviagen International, Inc.
    • 15.3.5. Neogen Corporation
    • 15.3.6. Zoetis Inc.
    • 15.3.7. CRV B.V.
    • 15.3.8. STgenetics, Inc.
    • 15.3.9. Genesus Inc.
    • 15.3.10. Lohmann Tierzucht GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GENETICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ANIMAL GENETICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ANIMAL GENETICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL GENETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL GENETICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GENETICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GENETICS MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GENETICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GENETICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GENETICS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CLONING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GENETICS MARKET SIZE, BY CRISPR/CAS9, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GENETICS MARKET SIZE, BY TALEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ZFN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GENOMIC SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MARKER ASSISTED SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GENETICS MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FEED EFFICIENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GENETICS MARKET SIZE, BY FERTILITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROWTH RATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GENETICS MARKET SIZE, BY MILK PRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GENETICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COMMERCIAL BREEDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL GENETICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL GENETICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL GENETICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANIMAL GENETICS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. GCC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. GCC ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. GCC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. GCC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 294. GCC ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 295. GCC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. GCC ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. GCC ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. GCC ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. G7 ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 328. G7 ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 336. G7 ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 337. G7 ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 338. G7 ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 339. G7 ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. G7 ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. NATO ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 342. NATO ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 343. NATO ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 344. NATO ANIMAL GENETICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 345. NATO ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2018-2024 (USD MILLION)
  • TABLE 346. NATO ANIMAL GENETICS MARKET SIZE, BY CATTLE, 2025-2032 (USD MILLION)
  • TABLE 347. NATO ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 348. NATO ANIMAL GENETICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 349. NATO ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2018-2024 (USD MILLION)
  • TABLE 350. NATO ANIMAL GENETICS MARKET SIZE, BY GENE EDITING, 2025-2032 (USD MILLION)
  • TABLE 351. NATO ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 352. NATO ANIMAL GENETICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 353. NATO ANIMAL GENETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 354. NATO ANIMAL GENETICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 355. GLOBAL ANIMAL GENETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)

TABLE